NYSE · PFE
Pfizer Inc.
$24.67 +$0.13 (+0.53%) 1D After hours
Session Pulse
After hours
chatter is
louder than usual
1
mentions on Sat
No new SEC filings since Tue close
its sector ranked
5/11
this week
Full pulse →
Key Metrics
$139.86B
Market cap
18.67×
P/E · TTM
$63.32B
Revenue · TTM
$7.49B
Net income
EPS · TTM
$1.31
Dividend yield
—
Free cash flow
$9.48B
Beta · 1Y
0.26
EBITDA · TTM
$14.49B
Gross margin
—
Snapshot
Market cap$139.86B
Enterprise value$194.40B
Shares outstanding5.7B
52-wk range$23.11 – $28.75
Avg volume · 20D36.2M
Net cash
−$54.53B
Book value / share$15.78
IndustryPharmaceutical Preparations
ExchangeNYSE
About Pfizer Inc.
IPO dateJun 22, 1951
Employees75000
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales.
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E18.67
P/S2.21
P/FCF14.75
EV/EBITDA13.41
EV/Sales3.07
Graham №$21.58
Profitability
Gross
—
Operating
12.5%
Net
11.8%
FCF
15.0%
ROE / ROIC
8.4% · 5.2%
Financial Health
Current ratio1.25
Quick ratio0.94
Debt / equity0.72
Debt / EBITDA
4.45
Net cash
−$54.53B
Working capital$8.47B
Cash Flow · TTM
Operating CF
$11.98B
Capex
−$2.50B
Free cash flow
$9.48B
Buybacks
—
Dividends paid
—
Shareholder yield
—
Piotroski F-Score
4 / 9
Middling fundamentals · 4 of 9 signals passing
Altman Z-Score
2.0
Grey zone (1.81–2.99) · monitor
Graham Number vs Price
$21.58 vs $24.67
Trades 1.1× above classic defensive value — priced for growth
Fundamentals through 2026-03-29 · computed by TickerWolf from SEC filings